美国 · SEC FORM 4
KYNTRA BIO, INC.
KYNB · Nasdaq · CIK 0000921299 · Healthcare · Biotechnology
内部人信号
1 位买方 · 2 条买入交易行 · $39.7K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ 角色得分低 · 买入者中职位最高的是：CEO（CEO、董事长和持股 10% 以上的股东得分最低）
- ⚠ Purchase activity is becoming less recent
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: CEO. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 35.2
- 35.2
- 35.2
- 35.1
- 35.1
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -23.4%
- 3M
- -16.8%
- 6M
- -14.8%
- 12M
- -46.4%
波动率与流动性
- 波动率
- 83.8%
- Beta
- —
- 平均每日成交额
- USD 110,543
估值
- 市值
- USD 24.7M
- P/E
- 0.1×
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, P/E · 财年截止日：2025-12-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-07-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 100,040
- 上期报告
- 100,711
- 日均成交量
- 26,755
- 回补天数
- 3.7
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Wettig Thane | 买入 (P) | Common Stock | 2,800 | USD 7.09 | USD 19,852 | SEC 申报 ↗ |
| 2026-05-14 | Wettig Thane | 买入 (P) | Common Stock | 2,800 | USD 7.09 | USD 19,852 | SEC 申报 ↗ |
| 2025-11-17 | Wettig Thane | 买入 (P) | Common Stock | 2,700 | USD 9.10 | USD 24,570 | SEC 申报 ↗ |
| 2025-11-13 | Wettig Thane | 买入 (P) | Common Stock | 1,000 | USD 9.18 | USD 9,180 | SEC 申报 ↗ |
| 2025-06-30 | Schoeneck James A | 买入 (P) | Common Stock | 23,567 | USD 5.07 | USD 119,485 | SEC 申报 ↗ |
| 2025-03-24 | Wettig Thane | 买入 (P) | Common Stock | 145,000 | USD 0.35 | USD 50,750 | SEC 申报 ↗ |
| 2025-03-21 | Schoeneck James A | 买入 (P) | Common Stock | 50,000 | USD 0.34 | USD 17,000 | SEC 申报 ↗ |
| 2025-03-20 | Schoeneck James A | 买入 (P) | Common Stock | 250,000 | USD 0.35 | USD 87,500 | SEC 申报 ↗ |
| 2024-06-12 | Adib Deyaa | 买入 (P) | Common Stock | 22,123 | USD 1.17 | USD 25,884 | SEC 申报 ↗ |
| 2024-03-07 | Wettig Thane | 买入 (P) | Common Stock | 50,000 | USD 1.91 | USD 95,500 | SEC 申报 ↗ |
| 2021-08-26 | Wettig Thane | 买入 (P) | Common Stock | 3,100 | USD 11.53 | USD 35,743 | SEC 申报 ↗ |
| 2020-06-11 | Conterno Enrique A | 买入 (P) | Common Stock | 19,800 | USD 35.28 | USD 698,544 | SEC 申报 ↗ |
| 2020-06-10 | Conterno Enrique A | 买入 (P) | Common Stock | 8,000 | USD 36.29 | USD 290,320 | SEC 申报 ↗ |
Form 4 申报证据
12 transaction lines in the latest 365-day window; 346 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-06 | Wettig Thane | 代扣税 (F) | Common Stock | 209 | USD 8.55 | USD 1,787 | SEC 申报 ↗ |
| 2026-09-06 | DeLucia David | 代扣税 (F) | Common Stock | 22 | USD 8.55 | USD 188 | SEC 申报 ↗ |
| 2026-06-06 | Wettig Thane | 代扣税 (F) | Common Stock | 198 | USD 6.71 | USD 1,329 | SEC 申报 ↗ |
展开近期 Form 4 证据 (12 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-06 | Wettig Thane | 代扣税 (F) | Common Stock | 209 | USD 8.55 | USD 1,787 | SEC 申报 ↗ |
| 2026-09-06 | DeLucia David | 代扣税 (F) | Common Stock | 22 | USD 8.55 | USD 188 | SEC 申报 ↗ |
| 2026-06-06 | Wettig Thane | 代扣税 (F) | Common Stock | 198 | USD 6.71 | USD 1,329 | SEC 申报 ↗ |
| 2026-06-06 | DeLucia David | 代扣税 (F) | Common Stock | 52 | USD 6.71 | USD 349 | SEC 申报 ↗ |
| 2026-05-14 | Wettig Thane | 买入 (P) | Common Stock | 2,800 | USD 7.09 | USD 19,852 | SEC 申报 ↗ |
| 2026-05-14 | Wettig Thane | 买入 (P) | Common Stock | 2,800 | USD 7.09 | USD 19,852 | SEC 申报 ↗ |
| 2026-03-06 | Wettig Thane | 代扣税 (F) | Common Stock | 277 | USD 6.84 | USD 1,895 | SEC 申报 ↗ |
| 2026-03-06 | DeLucia David | 代扣税 (F) | Common Stock | 60 | USD 6.84 | USD 410 | SEC 申报 ↗ |
| 2025-12-06 | Wettig Thane | 代扣税 (F) | Common Stock | 259 | USD 8.42 | USD 2,181 | SEC 申报 ↗ |
| 2025-12-06 | DeLucia David | 代扣税 (F) | Common Stock | 52 | USD 8.42 | USD 438 | SEC 申报 ↗ |
| 2025-11-17 | Wettig Thane | 买入 (P) | Common Stock | 2,700 | USD 9.10 | USD 24,570 | SEC 申报 ↗ |
| 2025-11-13 | Wettig Thane | 买入 (P) | Common Stock | 1,000 | USD 9.18 | USD 9,180 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | KYNB |
| CIK | 0000921299 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 346 transaction lines from 2020-01-06 to 2026-09-06 13 P purchase lines · 101 S sale lines · 232 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.